Mesothelioma
Coordonnateurs : Robinson Bruce W S, Chahinian A Philippe
Mesothelioma used to be a rare disease, but because of the widespread use of asbestos it has now been described as an epidemic around the world. The disease has proven exceptionally resistant to common forms of treatment (chemotherapy, radiotherapy and surgery). Mesothelioma has a very aggressive natural history with a median survival of around 9 months.
There has been an explosion in knowledge about mesothelioma in the past few years, partly stimulated by the formation of the International Mesothelioma Interest Group network. This book represents a state-of-the-art review of the disease, from laboratory through to the bedside, from diagnostic procedures through to treatment and from imaging and early detection through to medico-legal aspects. It will be of interest to any clinician or scientist with any involvement in asbestos-related diseases, as well as members of the legal profession and anyone with an interest in respiratory diseases.
'This book should be of interest to those taking care of patients with mesothelioma, and would make a good addition to the library of professionals concerned with occupational lung disease.' - CHEST
Date de parution : 10-2019
17.4x24.6 cm
Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).
Prix indicatif 50,12 €
Ajouter au panierDate de parution : 01-2002
Ouvrage de 380 p.
17.4x24.6 cm
Thèmes de Mesothelioma :
Mots-clés :
Co-stimulatory Molecules B7-1; Malignant Mesothelioma Cell Lines; Sarcomatoid Mesothelioma; Extrapleural Pneumonectomy; Pleural Plaques; Malignant Mesothelioma Cell; Peritoneal Mesothelioma; Mesothelial Cells; Mesothelioma Cell; Pleural Mesothelioma; Mesothelioma Cases; DNA Tumour Virus; Visceral Pleura; Pleural Fluid; Amphibole Asbestos; SV40 DNA; Desmoplastic Mesothelioma; SV40 Tag; Medical Thoracoscopy; Pleural Mesothelial Cells; Talc Poudrage; NSW Court; PDGF A-chain; Serous Carcinoma; Mesothelial Proliferations